Loading...
Loading...
A 7-variable clinical scoring tool that predicts ADAMTS13 activity < 10% (severe deficiency) and thus the probability of immune-mediated thrombotic thrombocytopenic purpura (TTP) in adults presenting with thrombotic microangiopathy (TMA). The PLASMIC score enables rapid risk stratification to guide initiation of plasma exchange before ADAMTS13 results are available, which may take 24–72 hours.
P — Platelet Count < 30 × 10⁹/L (30,000/µL)
L — Combined Hemolysis Variable (Any One of the Following)
A — No Active Cancer
S — No Stem Cell or Solid Organ Transplant History
M — Mean Corpuscular Volume (MCV) < 90 fL
I — INR < 1.5
C — Creatinine < 2.0 mg/dL (< 177 µmol/L)
Awaiting input
Fill in the parameters to see your result